Bone-building drug after ankle fracture surgery for high-risk adults
Part of Injuries & trauma clinical trials.
This trial tests whether a medication that helps build bone (Teriparatide) can improve healing after ankle fracture surgery in adults over 60 with certain health risks, such as diabetes or osteoporosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older.
- You have a broken ankle from a low-energy fall (like falling from standing height).
- Your ankle fracture requires surgery.
- You have at least one risk factor: diabetes, osteoporosis, kidney disease, steroid use, smoking history, nerve damage in legs (peripheral neuropathy), or blood vessel disease (vascular disease).
- You haven't taken Teriparatide (a bone-building drug) before.
- You don't have high calcium levels (hypercalcemia) or overactive parathyroid glands (hyperparathyroidism).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how best to manage serious ankle or tibia-pilon fractures in older adults who may be frail or have other major health problems. The goal is to improve care decisions and outcomes after injury, especially in people more likely to have complications.
This study tests a new exercise program called the Ankle Muscle Power (AMP) program to help people get back to full duty after an ankle fracture surgery. It aims to see if this program is effective and practical for recovery.
This trial tests teriparatide (a hormone-like bone medicine) to improve bone health in people with advanced chronic kidney disease who are at risk for weak, low-turnover bone. It may help by changing how quickly your bones break down and rebuild.
This trial tests teriparatide, a medication that helps build bone, to see if it can speed recovery and help certain enlisted Army members return to training duty after a tibia bone injury. You may be asked to self-administer the medication while you recover and take part in study follow-ups.
This study looks at ways to prevent and treat “brittle bone” refractures after a recent fracture in people with osteoporosis. If you’ve had a new hip, spine, or other bone fracture, the trial may test strategies to lower the chance of another fracture.
This trial tests a new injection called abaloparatide (QLG2128) for women after menopause who have weak bones (osteoporosis) and a high risk of breaking a bone. It aims to see if it helps strengthen bones and prevent fractures.
Hear when a new Ankle Fractures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.